NEW YORK (GenomeWeb News) - Transgenomic today said fourth-quarter revenues increased 9.4 percent as R&D spending rose roughly 28 percent and losses were cut by 91 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $5.8 million from $5.3 million year over year.
  
The growth came from sales of the company’s Discovery Services unit, OEM sales, and placements of the company’s WAVE system and related consumables, Transgenomic CEO Craig Tuttle said in a statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.